AllianceBernstein’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

AllianceBernstein’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,920	Closed	-$183K	–	3250
2022 Q4	$183K	Sell	17,920 -6,775	-27%	-$68.6K	﹤0.01%	3026
2022 Q3	$248K	Hold	24,695	–	–	﹤0.01%	2946
2022 Q2	$246K	Hold	24,695	–	–	﹤0.01%	2946
2022 Q1	$246K	Buy	+24,695	New	+$245K	﹤0.01%	2938

Other funds holding LVAC

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Quarry LP New York $558M AUM 23.92% 1-Year Est. Return

AllianceBernstein's LVAC Position: Q1 2023 in Review

AllianceBernstein sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q1 2023, closing a stake of 17,920 shares — an estimated $183K sold.

AllianceBernstein first reported a position in LVAC in Q1 2022 and held it in 4 quarters. The position peaked at $248K in Q3 2022. 54 funds tracked by Wall St. Rank hold LVAC as of Q1 2023.

AllianceBernstein reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
AllianceBernstein sold 17,920 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $183K.
AllianceBernstein first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 4 quarters.
AllianceBernstein's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $248K in Q3 2022.
54 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on AllianceBernstein's 13F filing for Q1 2023, filed 15 May 2023.